Literature DB >> 9302073

Neurotrophin signal transduction in medulloblastoma.

T T Chou1, J Q Trojanowski, V M Lee.   

Abstract

The members of the neurotrophin family play key biological roles in the development of the nervous system. Based on studies initially in cell lines (e.g., the rat pheochromocytoma PC12 cells), neurotrophins have been found to be important mediators of proliferation, differentiation, and survival in the normal brain, but their role in brain tumors remains unclear. Since neurotrophins and neurotrophin receptors are frequently detected in biopsy samples of central nervous system medulloblastomas, efforts have been undertaken in several laboratories to elucidate the potential effects of neurotrophins on the growth and differentiation of these tumors. Results from these studies may have both basic and clinical implications because medulloblastomas resemble embryonic neuroectodermal stem cells and/or their immature neuronal and glial progeny. This review focuses on recent developments in our understanding of the role of neurotrophins in medulloblastomas, especially the ability of nerve growth factor to induce apoptosis in vitro in medulloblastomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302073     DOI: 10.1002/(SICI)1097-4547(19970901)49:5<522::AID-JNR2>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line.

Authors:  Young-Hoon Kim; Seung Hee Cho; Soo Jung Lee; Seung Ah Choi; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Byung-Kyu Cho; Chae-Yong Kim
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

Review 2.  VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.

Authors:  Jincai Luo; Yan Xiong; Xiaofan Han; Yao Lu
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

3.  BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Authors:  Amanda Thomaz; Mariane Jaeger; Marienela Buendia; Victorio Bambini-Junior; Lauro José Gregianin; Algemir Lunardi Brunetto; André T Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

4.  BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.

Authors:  Anna Laura Schmidt; Caroline Brunetto de Farias; Ana Lucia Abujamra; Flávio Kapczinski; Gilberto Schwartsmann; Algemir Lunardi Brunetto; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2009-07-30       Impact factor: 3.444

5.  Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.

Authors:  Radhika Iyer; Lea Wehrmann; Rebecca L Golden; Koumudi Naraparaju; Jamie L Croucher; Suzanne P MacFarland; Peng Guan; Venkatadri Kolla; Ge Wei; Nicholas Cam; Gang Li; Zachary Hornby; Garrett M Brodeur
Journal:  Cancer Lett       Date:  2016-01-18       Impact factor: 8.679

6.  The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas.

Authors:  Cailei Zhao; Qian Chen; Chunde Li; Jian Yang; Cong Li; Yangyang Zhou; Jianxiang Liao
Journal:  Neurol Sci       Date:  2018-04-10       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.